Buzaglo, Joanne S. http://orcid.org/0000-0002-1839-3047
Zaleta, Alexandra K. http://orcid.org/0000-0002-8589-4722
McManus, Shauna http://orcid.org/0000-0001-8867-8024
Golant, Mitch
Miller, Melissa F. http://orcid.org/0000-0001-8288-2681
Funding for this research was provided by:
Genentech
Pfizer Oncology
Lilly Oncology
Bristol-Myers Squibb
AbbVie
Amgen Oncology
Astellas Pharma US
AstraZeneca
Bayer HealthCare
Boehringer Ingelheim
Celgene
Janssen Oncology
Jazz Pharmaceuticals
Novartis Pharmaceuticals Corporation
Pharmacyclics
Takeda Oncology
Article History
Received: 4 June 2018
Accepted: 18 March 2019
First Online: 12 April 2019
Compliance with ethical standards
:
: Support for the Cancer Experience Registry was provided by AbbVie, Inc.; Amgen Oncology; Astellas Pharma US, Inc.; AstraZeneca; Bayer HealthCare; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene Corporation; Genentech, Inc.; Janssen Oncology; Jazz Pharmaceuticals; Lilly Oncology; Novartis; Pfizer Oncology; Pharmacyclics, Inc.; and Takeda Oncology; research support was granted to the Cancer Support Community and not individual study authors. Cancer Support Community retains full control of all primary data.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.